DR-280 Genomic Correlates of Melanoma Outcomes

Recent advances in melanoma treatments have greatly improved patient survival. However, many patients still do not benefit, and we do not fully understand why some patients respond to treatment, while others do not. We have a cohort of melanoma patients with DNA and clinical data, that may help us understand this better. We aim to combine our study with other melanoma datasets from Hartwiig and other sources, to boost the strength and numbers of our study so that we will be better able to answer these questions.

Samra Turajlic, The Francis Crick Institute, United Kingdom